SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford GlycoSciences Plc -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (257)12/9/2002 10:50:03 PM
From: tuck  Read Replies (1) | Respond to of 469
 
Do you really think the FDA would go for this indication given the side effects? I have my doubts. It's not even acceptable to them for Gaucher's, much less infertility.

Cheers, Tuck



To: scaram(o)uche who wrote (257)12/9/2002 10:54:57 PM
From: keokalani'nui  Respond to of 469
 
Just joining the gaffaws about the second indication.

Agree about the the seriousness of what vevesca may first do for patients.